|
|
| News Archive |
JHS Secures Multi-Million Dollar Contracts to Manufacture Sterile Parenteral Products
Thursday, February 23, 2012
Company has secured contracts with four innovator life science companies.
Boehringer Ingelheim and Xencor Enter a Collaboration Agreement
Thursday, February 23, 2012
Antibodies engineered with Xencor’s proprietary Xtend™ technology for increasing antibody half-life.
Shire Announces European Approval of Manufacturing Facility for VPRIV®
Thursday, February 23, 2012
EMA approval adds significant capacity for the manufacture of Shire’s enzyme replacement therapies.
Theratechnologies Announces a Supply, Distribution and Licensing Agreement with Actelion
Thursday, February 23, 2012
Agreement provides Actelion with the exclusive commercialization rights to tesamorelin in Canada.
Genticel Completed Recruitment for its Phase Ib Vaccine Trial in HPV Infected Women
Wednesday, February 22, 2012
Company expects the final results before the end of the second quarter 2012.
Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of Debio 0932
Tuesday, February 21, 2012
Company expects to initiate a combination Phase I/II study in NSCLC patients in the second quarter of 2012.
PRECOS to Unveil New Service Portfolio at Cancer Targets & Therapeutics and AACR 2012
Tuesday, February 21, 2012
2012 conference examines new and emerging targets and therapeutics in the area of cancer research.
Honouring the Best Innovators, Pioneers and Leaders in Asia
Tuesday, February 21, 2012
The BioPharma Awards aims to acknowledge the dedication and success of industry leaders and companies globally and in Asia.
TxCell Presents Immuno-Monitoring Results of its Phase I/II Clinical Trial
Tuesday, February 21, 2012
Results supportive of Ovasave(R) mechanism of action were presented at the seventh European Crohn’s and Colitis Organization (ECCO) meeting in Barcelona.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 1478 |
|
|
